{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:31:04Z","timestamp":1790487064211,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"14","license":[{"start":{"date-parts":[[2013,4,26]],"date-time":"2013-04-26T00:00:00Z","timestamp":1366934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2013,7,15]]},"abstract":"<jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Outcomes for patients with chronic myeloid leukemia (CML) have improved after the advent of tyrosine kinase inhibitors (TKIs), which target the <jats:italic>BCR\/ABL<\/jats:italic> fusion gene product. Nonetheless, differences in survival persist between age groups. The authors performed a retrospective cohort study using the Surveillance, Epidemiology, and End Results (SEER) database to assess 5\u2010year overall survival (OS) in various patient age groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Patients who had a diagnosis of CML were identified using the SEER 19 registries database. Patients who were included had SEER diagnosis codes for CML not otherwise specified (code 9863) and BCR\/ABL\u2010positive CML (code 9875) diagnosed between January 2000 and December 2005. Patients were divided into cohorts based on age at diagnosis: ages 15 to 44 years, 45 to 64 years, 65 to 74 years, and 75 to 84 years. OS was estimated using the Kaplan\u2010Meier method, and Cox regression was used to estimate predictors of patient survival.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>In total, 5138 patients with a new CML diagnosis were identified. Five\u2010year OS improved for all patients between the years 2000 and 2005. Compared with patients who were diagnosed in 2000, 5\u2010year survival improved among patients ages 15 to 44 years (hazard ratio [HR] for mortality, 0.424; P\u2009&lt;\u2009.0001), ages 45 to 64 years (HR, 0.716; P\u2009=\u2009.0315), and ages 65 to 74 years (HR, 0.692; P\u2009=\u2009.0126); and patients ages 75 to 84 years had an increased 5\u2010year OS rate from 19.2% in 2000 to 36.4% in 2005 (HR, 0.568; P\u2009&lt;\u2009.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>OS at 5 years improved among all patients, including those ages 75 to 84 years, a group with historically poor outcomes. However, older age retained an association with worse survival, suggesting opportunities for further progress. <jats:bold><jats:italic>Cancer<\/jats:italic> 2013;119:2620\u20102629.<\/jats:bold> \u00a9 <jats:italic>2013 American Cancer Society<\/jats:italic>.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.28106","type":"journal-article","created":{"date-parts":[[2013,4,26]],"date-time":"2013-04-26T09:50:58Z","timestamp":1366969858000},"page":"2620-2629","source":"Crossref","is-referenced-by-count":60,"title":["Trends in all\u2010cause mortality among patients with chronic myeloid leukemia"],"prefix":"10.1002","volume":"119","author":[{"given":"Andrew M.","family":"Brunner","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital\/Harvard Medical School Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Campigotto","sequence":"additional","affiliation":[{"name":"Dana Farber Cancer Institute Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Sadrzadeh","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital\/Harvard Medical School Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Drapkin","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital\/Harvard Medical School Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi\u2010Bin","family":"Chen","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital\/Harvard Medical School Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna S.","family":"Neuberg","sequence":"additional","affiliation":[{"name":"Dana Farber Cancer Institute Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir T.","family":"Fathi","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital\/Harvard Medical School Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,4,26]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/300765a0"},{"key":"e_1_2_7_3_1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1182\/blood.V70.2.448.448","article-title":"CML patients in blast crisis have breakpoints localized to a specific region of the BCR","volume":"70","author":"Schaefer\u2010Rego K","year":"1987","journal-title":"Blood."},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2406902"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11316"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.7146"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441402"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10239"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2012.01.001"},{"key":"e_1_2_7_10_1","first-page":"935","article-title":"Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia","volume":"8","author":"Cohen MH","year":"2002","journal-title":"Clin Cancer Res."},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.13045"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-324228"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23330"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0393"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(96)00006-6"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.6.962"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.03.018"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2011.10.001"},{"key":"e_1_2_7_20_1","unstructured":"National Cancer Institute DCCPS Surveillance Research Program Surveillance Systems Branch.Surveillance Epidemiology and End Results (SEER) Program Research Data (1973\u20102009) released April 2012 based on the November 2011 submission.2012. Available at:www.seer.cancer.gov. Accessed October 16 2012."},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20138"},{"key":"e_1_2_7_22_1","volume-title":"International Classification of Diseases for Oncology","author":"Percy C","year":"2000"},{"key":"e_1_2_7_23_1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.COT.0000285935.06478.5e","article-title":"New NCCN CML guidelines incorporate use of imatinib","volume":"24","author":"Susman E","year":"2002","journal-title":"Oncol Times."},{"key":"e_1_2_7_24_1","first-page":"1","article-title":"United States life tables, 2000","volume":"51","author":"Arias E","year":"2002","journal-title":"Natl Vital Stat Rep."},{"key":"e_1_2_7_25_1","unstructured":"United States Census Bureau.Census 2000 Gateway. Available at:http:\/\/www.census.gov\/main\/www\/cen2000.html. Accessed October 21 2012."},{"key":"e_1_2_7_26_1","unstructured":"United States Department of Agriculture Economic Research Service.2003 Rural\u2010Urban Continuum Codes. Available at:http:\/\/www.ers.usda.gov\/data\u2010products\/rural\u2010urban\u2010continuum\u2010codes.aspx. Accessed November 16 2012."},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951115)76:10<1687::AID-CNCR2820761002>3.0.CO;2-I"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V66.6.1326.1326"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.11.850"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-358135"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11629"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2010.07.001"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.07.023"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.214"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403756"},{"key":"e_1_2_7_36_1","unstructured":"Surveillance Epidemiology and End Results (SEER) Program.Population Characteristics: Characteristics of the SEER Population Compared with the Total United States Population. Available at:http:\/\/seer.cancer.gov\/registries\/characteristics.html. Accessed October 21 2012."}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.28106","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.28106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:27:13Z","timestamp":1760300833000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.28106"}},"subtitle":["A Surveillance, Epidemiology, and End Results database analysis"],"short-title":[],"issued":{"date-parts":[[2013,4,26]]},"references-count":35,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2013,7,15]]}},"alternative-id":["10.1002\/cncr.28106"],"URL":"https:\/\/doi.org\/10.1002\/cncr.28106","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,26]]}}}